117 related articles for article (PubMed ID: 2678131)
1. Intravenous prostavasin--therapy in peripheral arterial occlusive disease in Fontaine's stages III and IV. Early and late results of a screening study.
Heidrich H; Meuche C; Ranft J; Rummel S; Peters A
Prog Clin Biol Res; 1989; 301():411-6. PubMed ID: 2678131
[No Abstract] [Full Text] [Related]
2. [Experience with intravenous prostaglandin E1 in stage II b arterial occlusive disease].
Dé P; Hepp W
Vasa Suppl; 1990; 30():139-41. PubMed ID: 2075565
[No Abstract] [Full Text] [Related]
3. [Pilot study of the effect of intravenous prostavasin therapy of inpatients with diabetes mellitus and IIb arterial occlusive disease].
Rosak C; Hofmann U; König P; Nitsche GB
Vasa Suppl; 1991; 33():339-40. PubMed ID: 1788748
[No Abstract] [Full Text] [Related]
4. Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV.
Balzer K; Rogatti W; Rüttgerodt K
Vasa Suppl; 1989; 28():31-8. PubMed ID: 2609242
[TBL] [Abstract][Full Text] [Related]
5. [Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease].
Stiegler H; Diehm C; Grom E; Martin M; Mörl H; Rudofsky G; Vogelberg KH
Vasa Suppl; 1992; 35():164-6. PubMed ID: 1481031
[No Abstract] [Full Text] [Related]
6. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
Creutzig A; Caspary L; Alexander K
Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
[No Abstract] [Full Text] [Related]
7. [Reflex oximetry for evaluating blood redistribution in patients with arterial occlusive disease treated with PGE1].
Thum J; Caspary L; Creutzig A; Alexander K
Vasa Suppl; 1992; 35():39-41. PubMed ID: 1481056
[No Abstract] [Full Text] [Related]
8. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
Rudofsky G
Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
[No Abstract] [Full Text] [Related]
9. [Controlled long-term blood pressure measurement with intravenous prostaglandin E1 infusion].
Heidrich H; Brodel C; Meuche C; Hellmann M; Ranft J
Vasa; 1991; 20(1):13-6. PubMed ID: 2031393
[TBL] [Abstract][Full Text] [Related]
10. [Randomized study comparing the clinical effectiveness of intravenous prostaglandin E1 and intravenous pentoxifylline in patients with Fontaine stage IIb arterial occlusive disease].
Hepp W; von Bary S; Corovic D; Diehm C; Mühe E; Rudofsky G; Scheffler P; Trübestein G; Vogelpohl M
Vasa Suppl; 1991; 33():348-9. PubMed ID: 1788753
[No Abstract] [Full Text] [Related]
11. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
Scheffler P; de la Hamette D; Leipnitz G
Vasa Suppl; 1991; 33():343-4. PubMed ID: 1788750
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for therapeutic studies in Fontaine's stages II-IV peripheral arterial occlusive disease. German Society of Angiology.
Heidrich H; Cachovan M; Creutzig A; Rieger H; Trampisch HJ
Vasa; 1995; 24(2):107-19. PubMed ID: 7793141
[No Abstract] [Full Text] [Related]
13. [Long-term blood pressure measurements with i.v. prostaglandin E1 infusion].
Heidrich H; Brodel C; Meuche C; Hellmann G; Ranft J
Vasa Suppl; 1989; 27():46. PubMed ID: 2623542
[No Abstract] [Full Text] [Related]
14. [Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)].
Ratschow R
MMW Munch Med Wochenschr; 1976 Sep; 118(36):1131-4. PubMed ID: 823407
[TBL] [Abstract][Full Text] [Related]
15. [Intravenous PGE-1 in peripheral vascular obstructive disease: use over a 6-month period].
Llorente Gutiérrez J; González Fernández MA; Fuentes Irigoyen R; Jiménez Caballero E
Farm Hosp; 2004; 28(3):188-91. PubMed ID: 15222872
[TBL] [Abstract][Full Text] [Related]
16. Plasma endothelin-1 levels in patients with peripheral arterial occlusive disease at different Fontaine's stages.
Mangiafico RA; Malatino LS; Santonocito M; Sarnataro F; Dell'Arte S; Messina R; Santangelo B
Panminerva Med; 1999 Mar; 41(1):22-6. PubMed ID: 10230252
[TBL] [Abstract][Full Text] [Related]
17. [Effect of intravenous naftidrofuryl on the microcirculation of patients in stages III and IV of arterial occlusive disease].
Abendroth D; Sunder-Plassmann L
Vasa Suppl; 1988; 24():33-7. PubMed ID: 3212601
[No Abstract] [Full Text] [Related]
18. Intraarterial prostaglandine E1 in arterial occlusive disease (AOD) stages III and IV.
Herold A; Bruch HP; Hörl M; Düsel W
Prog Clin Biol Res; 1987; 242():439-44. PubMed ID: 2959966
[TBL] [Abstract][Full Text] [Related]
19. [Quality of life in peripheral arterial occlusive disease. Multicenter study of quality of life characteristics with a newly developed disease-specific questionnaire].
Heidrich H; Bullinger M; Cachovan M; Creutzig A; Diehm C; Gruss JD; Kirchberger I; Loeprecht H; Rogatti W
Med Klin (Munich); 1995 Dec; 90(12):693-7. PubMed ID: 8583985
[TBL] [Abstract][Full Text] [Related]
20. Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter study.
Trübestein G; von Bary S; Breddin K; Diehm C; Gruss JD; Heinrich H; Horsch S; Kriessmann A; Maass U; Martin M
Vasa Suppl; 1989; 28():44-9. PubMed ID: 2692200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
